Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Oral and poster presentations highlight progress across cardiac genetic medicine pipeline and optimized,

Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

April 27, 2026 17:00 ET  | Source: Arbor Biotechnologies Inc – Oral presentation highlights novel compact RT editor demonstrating first preclinical in vivo proof of concept for precise gene editing in the CNS delivered via a single AAV – Poster presentations showcase deepening platform capabilities to develop genomic medicines for neurodegenerative diseases and beyond CAMBRIDGE, […] The post Arbor Biotechnologies to Present Expansion of CNS Edit…